Interleukin-7 optimizes FOXP3+CD4+ regulatory T cells reactivity to interleukin-2 by modulating CD25 expression.
about
IL-7R signaling in regulatory T cells maintains peripheral and allograft tolerance in mice.Tertiary lymphoid structures, drivers of the anti-tumor responses in human cancers.Single and combined effect of retinoic acid and rapamycin modulate the generation, activity and homing potential of induced human regulatory T cells.
P2860
Interleukin-7 optimizes FOXP3+CD4+ regulatory T cells reactivity to interleukin-2 by modulating CD25 expression.
description
2014 nî lūn-bûn
@nan
2014 թուականի Դեկտեմբերին հրատարակուած գիտական յօդուած
@hyw
2014 թվականի դեկտեմբերին հրատարակված գիտական հոդված
@hy
2014年の論文
@ja
2014年論文
@yue
2014年論文
@zh-hant
2014年論文
@zh-hk
2014年論文
@zh-mo
2014年論文
@zh-tw
2014年论文
@wuu
name
Interleukin-7 optimizes FOXP3+ ...... by modulating CD25 expression.
@ast
Interleukin-7 optimizes FOXP3+ ...... by modulating CD25 expression.
@en
type
label
Interleukin-7 optimizes FOXP3+ ...... by modulating CD25 expression.
@ast
Interleukin-7 optimizes FOXP3+ ...... by modulating CD25 expression.
@en
prefLabel
Interleukin-7 optimizes FOXP3+ ...... by modulating CD25 expression.
@ast
Interleukin-7 optimizes FOXP3+ ...... by modulating CD25 expression.
@en
P2093
P2860
P1433
P1476
Interleukin-7 optimizes FOXP3+ ...... by modulating CD25 expression.
@en
P2093
Christine Bourgeois
Nicolas Gestermann
Stéphane Bloquet
P2860
P304
P356
10.1371/JOURNAL.PONE.0113314
P407
P577
2014-12-08T00:00:00Z